Oppenheimer analyst Steven Lichtman raised the price target on Medtronic, Inc. (NYSE: MDT) to $104.00 (from $96.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Medtronic (MDT) Declares $0.50 Annual Dividend; 0.5% YieldAugust 24, 2018 4:34 PM Medtronic, Inc. (MDT) PT Raised to $101 at Wells FargoAugust 22, 2018 7:44 AM Medtronic, Inc. (MDT) PT Raised to $105 at Morgan StanleyAugust 22, 2018 7:01 AM Medtronic, Inc. (MDT) PT Raised to $104 at RBC CapitalAugust 21, 2018 5:42 PM Medtronic, Inc. (MDT) PT Raised to $103 at Evercore ISIAugust 21, 2018 4:40 PM Medtronic, Inc. (MDT) PT Raised to $105 at CowenAugust 21, 2018 2:06 PM Medtronic, Inc. (MDT) PT Raised to $109 at JefferiesAugust 21, 2018 12:58 PM Medtronic (MDT) Tops Q1 EPS by 6c, Offers GuidanceAugust 21, 2018 6:48 AM Medtronic Reports First Quarter Financial ResultsAugust 21, 2018 6:46 AM